Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Gainers
- JanOne Inc. (NASDAQ:JAN) shares climbed 97.7% to $5.04 after the company announced it purchased a worldwide exclusive license for TV1001SR, a treatment for peripheral arterial disease. No terms were disclosed.
- The Peck Company Holdings, Inc. (NASDAQ:PECK) gained 68.1% to $3.85.
- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) shares rose 46.9% to $2.35 after the company announced it has recieved and rejected an unsolicited, all cash proposal from two biopharmaceutical companies between $3-$5 per share in cash.
- The Medicines Company (NASDAQ:MDCO) shares rose 22.4% to $83.87 after the company announced it will be acquired by Novartis AG for $85 per share.
- Aquestive Therapeutics, Inc. (NASDAQ:AQST) shares rose 21.7% to $7.83 after the company received the FDA approval for EXSERVAN for the treatment of amyotrphic lateral sclerosis.
- Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) gained 16.3% to $57.22 after Baird upgraded the company's stock from Neutral to Outperform and raised the price target from $39 to $70.
- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) climbed 13.1% to $2.545.
- InMode Ltd. (NASDAQ:INMD) gained 12.7% to $46.81. This could potentially be a rebound after the stock the dropped approximately 23% over the past 4 trading sessions
- IEC Electronics Corp. (NYSE:IEC) shares rose 10.8% to $8.64.
- Five Prime Therapeutics, Inc. (NASDAQ:FPRX) climbed 10.5% to $3.91.
- Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) rose 10.5% to $98.22. Intercept Pharma disclosed that the FDA has accepted New Drug Application for obeticholic acid for the treatment of fibrosis due to nonalcoholic steatohepatitis and granted priority review.
- IVERIC bio, Inc. (NASDAQ:ISEE) climbed 10.2% to $3.6350
- Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) gained 9.5% to $3.7994.
- Zynex, Inc. (NASDAQ:ZYXI) gained 9.5% to $9.80.
- Kamada Ltd. (NASDAQ:KMDA) rose 9% to $7.51.
- Chico's FAS, Inc. (NYSE:CHS) climbed 8.7% to $4.075 in anticipation of the company's Q3 earnings scheduled for tomorrow before the open.
- ArQule, Inc. (NASDAQ:ARQL) gained 8.2% to $8.86. The company earlier announced it will present clinical data from its Phase 1 study of ARQ 531 at the ASH Annual Meeting on December 9th.
- U.S. Silica Holdings, Inc. (NYSE:SLCA) gained 8.1% to $4.92.
- Zscaler, Inc. (NASDAQ:ZS) shares rose 6.1% to $49.15 after Bank of America upgraded the company's stock from Neutral to Buy.
- Tiffany & Co. (NYSE:TIF) rose 6% to $133.06 after LVMH confirmed an agreement to buy the company in a $16.2 billion bid.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Check out these big penny stock gainers and losers
Losers
- CymaBay Therapeutics Inc (NASDAQ:CBAY) shares tumbled 76.2% to $1.32 after the company reported a halt in the clinical development of its Seladelpar.
- La Jolla Pharmaceutical Company (NASDAQ:LJPC) fell 55.2% to $2.50 after the company reported that President and CEO George Tidmarsh has left the company. La Jolla Pharmaceutical disclosed that it will reassess continued development of LJPC-401 based on recent clinical results.
- Adamis Pharmaceuticals Corp (NASDAQ:ADMP) shares dropped 48.8% to $0.6449 after the company reported it received a complete response letter from the FDA for its ZIMHI. The FDA stated it cannot approve the ZIMHI in its present form and provided suggested needed for resubmission.
- BlueLinx Holdings Inc. (NYSE:BXC) fell 28.2% to $8.93.
- AMERI Holdings, Inc. (NASDAQ:AMRH) shares dropped 19.6% to $2.19.
- Kirkland Lake Gold Ltd (NYSE:KL) shares dipped 16% to $40.02 after the company, along with Detour Gold, announced Kirkland Lake Gold will acquire all of the issued and outstanding securities of Detour Gold.
- Kazia Therapeutics Limited (NASDAQ:KZIA) fell 16.7% to $6.17 after reporting interim data from ongoing Phase 2 study of GDC-0084 in glioblastoma.
- Vislink Technologies Inc (NASDAQ:VISL) tumbled 15.3% to $0.25. Vislink Technologies priced its common stock and warrant offering for $4 million.
- Akerna Corp. (NASDAQ:KERN) dipped 12.9% to $6.31.
- CANAAN INC. (NASDAQ:CAN) fell 12.4% to $7.87. The stock has been volatile since Thursday's IPO, in which it opened at $12.60, above the IPO price of $9.
- Surface Oncology, Inc. (NASDAQ:SURF) shares declined 11.7% to $2.0573 after the company reported a $25 million debt financing from K2 HealthVentures.
- GTT Communications, Inc. (NYSE:GTT) fell 8.1% to $5.12.
- Silvergate Capital Corporation (NYSE:SI) shares dropped 7.7% to $14.46.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.